Research Article
Noninvasive Identification of Immune-Related Biomarkers in Hepatocellular Carcinoma
Table 6
Clinical characteristics of participants.
| | Group | Hepatocellular carcinoma (HCC) (n = 20) | Healthy individuals |
| | Gender | | | | Male | 13 | 12 | | Female | 7 | 8 | | Age | 55 (42–76) | 43 (20–65) | | Alpha-fetoprotein (AFP) | | | | >20 ng/ml | 20 | 0 | | <20 ng/ml | 0 | 20 | | Tumor size | 5.57 (2.7–8.6) | — | | ≤3 cm | 2 | — | | 3–5 cm | 9 | — | | >5 cm | 7 | — | | Not available | 2 | — | | Barcelona Clinic Liver Cancer (BCLC) stage | | | | Stage 0 | 0 | — | | Stage A | 9 | — | | Stage B | 7 | — | | Stage C | 0 | — | | Stage D | 0 | — | | Not available | 4 | — | | Viral infection | | | | HBV | 20 | 0 | | HCV | 0 | 0 | | Alcohol | 0 | 0 | | None | 0 | 20 | | TNM stage | | | | T1 | 18 | — | | T2 | 2 | — | | T3 | 0 | — | | T4 | 0 | — | | Not available | 0 | — |
|
|
